V W-S Wong1,2,3, G L-H Wong1,2,3, H-Y Chan1,2,3, D K-W Yeung4, R S-M Chan1,5, A M-L Chim1,2,3, C K-M Chan1,2,3, Y-K Tse1,2, J Woo1,5, W C-W Chu2,6, H L-Y Chan1,2,3. 1. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong. 2. Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong. 3. State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong. 4. Department of Clinical Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong. 5. Centre for Nutritional Studies, The Chinese University of Hong Kong, Shatin, Hong Kong. 6. Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong.
Abstract
BACKGROUND: Patients with non-alcoholic steatohepatitis (NASH) have increased intestinal permeability and small intestine bacterial overgrowth. AIMS: To test the hypothesis that endotoxemia is associated with non-alcoholic fatty liver disease (NAFLD) in the general population, and to study dietary factors associated with endotoxemia. METHODS: Nine hundred and twenty adults were randomly selected from the government's census database and underwent proton-magnetic resonance spectroscopy to assess hepatic steatosis. Endotoxemia was assessed using the limulus amebocyte lysate, lipopolysaccharide-binding protein (LBP) and EndoCab immunoglobulin G (IgG) assays. RESULTS: Two hundred and sixty-three (29%) subjects had NAFLD. Subjects with NAFLD had slightly higher LBP (P < 0.001) and EndoCab IgG (P = 0.013) levels. EndoCab IgG remained an independent factor associated with intrahepatic triglycerides after adjusting for other metabolic factors. Among 565 subjects without NAFLD at baseline who had repeated assessment at a median interval of 47 months, 78 (13.8%) developed incident NAFLD and they also had higher LBP (P = 0.016). Moreover, LBP was associated with insulin resistance and dyslipidaemia, and modestly increased with the cytokeratin-18 fragment level but not liver stiffness measurement by transient elastography. Although total energy consumption and individual macronutrients were not associated with endotoxemia, current drinkers (mostly <140 g/week) had lower endotoxin, EndoCab IgG and fetuin-A levels than nondrinkers. CONCLUSIONS: Endotoxin markers are associated with NAFLD in the general population, but do not have a major effect on NASH and fibrosis. People with modest alcohol consumption have lower serum endotoxin. This may partly explain the lower risk of NAFLD and NASH in modest drinkers in previous observational studies.
BACKGROUND:Patients with non-alcoholic steatohepatitis (NASH) have increased intestinal permeability and small intestine bacterial overgrowth. AIMS: To test the hypothesis that endotoxemia is associated with non-alcoholic fatty liver disease (NAFLD) in the general population, and to study dietary factors associated with endotoxemia. METHODS: Nine hundred and twenty adults were randomly selected from the government's census database and underwent proton-magnetic resonance spectroscopy to assess hepatic steatosis. Endotoxemia was assessed using the limulus amebocyte lysate, lipopolysaccharide-binding protein (LBP) and EndoCab immunoglobulin G (IgG) assays. RESULTS: Two hundred and sixty-three (29%) subjects had NAFLD. Subjects with NAFLD had slightly higher LBP (P < 0.001) and EndoCab IgG (P = 0.013) levels. EndoCab IgG remained an independent factor associated with intrahepatictriglycerides after adjusting for other metabolic factors. Among 565 subjects without NAFLD at baseline who had repeated assessment at a median interval of 47 months, 78 (13.8%) developed incident NAFLD and they also had higher LBP (P = 0.016). Moreover, LBP was associated with insulin resistance and dyslipidaemia, and modestly increased with the cytokeratin-18 fragment level but not liver stiffness measurement by transient elastography. Although total energy consumption and individual macronutrients were not associated with endotoxemia, current drinkers (mostly <140 g/week) had lower endotoxin, EndoCab IgG and fetuin-A levels than nondrinkers. CONCLUSIONS: Endotoxin markers are associated with NAFLD in the general population, but do not have a major effect on NASH and fibrosis. People with modest alcohol consumption have lower serum endotoxin. This may partly explain the lower risk of NAFLD and NASH in modest drinkers in previous observational studies.
Authors: Elizabeth C Townsend; Grace Y Zhang; Rabab Ali; Pallavi Surana; Marian Firke; Mi Sun Moon; Ma Ai Thanda Han; Meital Gewirtz; James A Haddad; David E Kleiner; Christopher Koh; Theo Heller Journal: Open Forum Infect Dis Date: 2020-10-20 Impact factor: 4.423
Authors: Tianyu He; Cuiling Xu; Noah Krampe; Stephanie M Dillon; Paola Sette; Elizabeth Falwell; George S Haret-Richter; Tiffany Butterfield; Tammy L Dunsmore; William M McFadden; Kathryn J Martin; Benjamin B Policicchio; Kevin D Raehtz; Ellen P Penn; Russell P Tracy; Ruy M Ribeiro; Daniel N Frank; Cara C Wilson; Alan L Landay; Cristian Apetrei; Ivona Pandrea Journal: J Clin Invest Date: 2019-12-02 Impact factor: 14.808
Authors: Michael Fricker; Bridie J Goggins; Sean Mateer; Bernadette Jones; Richard Y Kim; Shaan L Gellatly; Andrew G Jarnicki; Nicholas Powell; Brian G Oliver; Graham Radford-Smith; Nicholas J Talley; Marjorie M Walker; Simon Keely; Philip M Hansbro Journal: JCI Insight Date: 2018-02-08
Authors: Wei Perng; Jacob E Friedman; Rachel C Janssen; Deborah H Glueck; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2022-06-16 Impact factor: 6.134